<DOC>
	<DOCNO>NCT02077192</DOCNO>
	<brief_summary>The purpose study determine whether fostamatinib safe effective treating patient persistent/chronic Immune Thrombocytopenic Purpura ( ITP ) 2 year period .</brief_summary>
	<brief_title>Open Label Study R788 Treatment Persistent/Chronic Immune Thrombocytopenic Purpura ( ITP )</brief_title>
	<detailed_description />
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<criteria>Completed discontinue early Study C935788047 Study C935788 048 Able willing give write informed consent Discontinued participation Study C935788047 Study C935788048 reason lack response Poorly control hypertension Study C935788047 Study C935788048 Significant infection , acute infection influenza , know inflammatory process</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>